Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{170431,
        author = {Chanchal Navnath Gaikwad and Mr. Bendre Suraj D. and Chaitanya Navnath Gaikwad},
        title = {FORMULATION AND EVALUATION OF  TOPICAL ANTIFUNGAL EMULGEL},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {7},
        pages = {1324-1331},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=170431},
        abstract = {Restricted treatment of vaginal candidiasis could work on the helpful results of patients with vaginal candidiasis as well as diminish drug measurements and dosing span. The point of the research project was to create fluconazole emulgel definitions, and assess their physicochemical, drug discharge, antifungal, security, and dependability profile, for likely treatment of vaginal candidiasis. (Bangarwa S & 1:48-55.) Thickener and HPMC E5LV-based fluconazole emulgels were arranged utilizing the unconstrained emulsification technique and their physicochemical properties, drug content, drug discharge profile, hostile to parasitic action against Candida albicans, in vivo vaginal biocompatibility and solidness profile were assessed utilizing standard conventions. The fluconazole emulgels displayed agreeable properties: pH: 5.2-5.4; spreadability: 1.6-2.5 cm; clear thickness: 85-314 cP; zone of restraint against Candida albicans: 22-38 mm; drug content: 91-102 %, and vaginal biocompatibility. [15] All the contemplated fluconazole emulgels displayed controlled fluconazole discharge north of 6 h and their medication discharge energy fitted well with Korsmeyer-Peppas model. HPMC-based emulgels showed unacceptable ongoing security profile. As far as anyone is concerned, this is the first report where thickener and HPMC E5LV-based fluconazole emulgels have been read up for conceivable treatment of vaginal candidiasis. Thickener based fluconazole emulgels are promising drug plans that could lessen the medication measurements and dosing recurrence. What's more, they could act as elective dose structures to Flucos gel. Fluconazole is a new triazole antifungal medication that is utilized in the treatment of shallow and fundamental parasitic contamination. The oral utilization of fluconazole isn't abundantly suggested as it makes many side impacts. Subsequently this plan is made for better persistent consistence and to decrease the portion of the medication and to stay away from the secondary effects like liver harm and kidney harm. This examination was intended to plan and assess different definition of an effective gel containing fluconazole by involving a polymer with various focus as Carbopol 940 and NaCMC. Methanol was utilized as an entrance enhancer.The assessment of planned fluconazole effective gel was completed for an actual appearance, pH-esteem, spreadability, homogeneity, drug content. The planned gel showed great actual qualities. The plan F3 (101.18%) and F6 (105.4%) show great medication content as the polymer fixation in them was higher. The rate yield of F4 (98.26%) was the most raised . The spreadability of gel diminishes with an increment in polymer focus. The pH of the plan was in the scope of 5-8 which is thought of as OK to keep away from the gamble of aggravation upon application to the skin},
        keywords = {Fluconazole; Fluconazole emulgels  Antifungal  Physicochemical  Controlled drug release,  In vivo vaginal biocompatibility  Stability Carbopol 940; Sodium Carboxy Methyl Cellulose; Topical Drug delivery system.},
        month = {December},
        }